Supporting IVD testing and clinical research
Perform and develop diagnostic assays and fuel clinical research applications with sequencing and array scanning on one instrument
When used in diagnostic mode on the NextSeq 550Dx, Illumina DNA Prep with Enrichment Dx supports user-supplied probe panels that meet the required specifications, including fixed and custom panels of varying sizes.
Illumina DNA Prep with Enrichment Dx
An FDA-regulated and IVDR-compliant library preparation and enrichment solution for in vitro diagnostic (IVD) targeted sequencing applications.
NextSeq 550Dx High Output Reagent Kit v2.5 (300 cycles)
Sequencing reagents offering a simplified workflow and high data quality for in vitro diagnostic (IVD) testing.
Integrated-on instrument solution for creating a sequencing run, monitoring run status, analyzing sequencing data, and viewing results.
Illumina DNA Prep with Enrichment Dx App with DRAGEN Server for NextSeq 550Dx*
The DRAGEN server features an integrated Field Programmable Gate Array (FPGA) chip for accurate, ultrarapid next-generation sequencing (NGS) secondary data analysis with NextSeq 550Dx and a dedicated analysis module for Illumina DNA Prep with Enrichment Dx.
*Available only in select countries.
VeriSeq NIPT Solution v2 detects aneuploidies 21, 18, and 13, rare autosomal aneuploidies, sex chromosome aneuploidies, and partial duplications and deletions ≥7 Mb for all autosomes as part of a clinical prenatal screening solution run on the NextSeq 550Dx Instrument.
A comprehensive in-lab NIPT IVD solution including reagents, instruments, and software for accurate aneuploidy screening results in 26 hours.
NextSeq 550Dx High Output Reagent Kit v2.5 (75 cycles)
Sequencing reagents offering a simplified workflow and high data quality for in vitro diagnostic (IVD) testing.
Integrated on-instrument data analysis solution available preinstalled on the VeriSeq Onsite Server v2.
TruSight Oncology Comprehensive (EU) is a CE-marked IVD comprehensive genomic profiling (CGP) test for analyzing multiple DNA and RNA variants plus biomarker signatures such as TMB and MSI across multiple cancer types. Indicated for use on the NextSeq 550Dx Instrument, TruSight Oncology Comprehensive (EU) consolidates multiple biomarkers into a single test and enables targeted therapies and clinical trials with actionable, easy-to-interpret results.
TruSight Oncology Comprehensive (EU)
The first CE-marked IVD kitted solution for comprehensive genomic profiling (CGP) of DNA and RNA variants, plus MSI and TMB, for multiple solid tumor types.
NextSeq 550Dx High Output Reagent Kit v2.5 (300 cycles)
Sequencing reagents offering a simplified workflow and high data quality for in vitro diagnostic (IVD) testing.
Local Run Manager TruSight Oncology Comprehensive (EU) Analysis Module (on-instrument software)
The TruSight Tumor 170 workflow covers 170 genes associated with common solid tumors. It simultaneously analyzes DNA and RNA, covering a wide range of genes and variant types.
Comprehensive assay targeting DNA and RNA variants from the same FFPE tumor sample.
Assay targeting multiple variant types, including tumor mutational burden (TMB) and microsatellite instability (MSI), even from low-quality samples.
NextSeq 500/550 v2.5 Reagent Kits
Ready-to-use reagent kits include the reagent cartridge, flow cell, and buffer. Multiple sequencing output and read length options available.
TruSight Tumor 170 BaseSpace app
Analysis of reads from DNA and RNA libraries prepared using the TruSight Tumor 170 panel.
Investigate the protein-coding regions of the genome to uncover genetic influences on disease and population health.
Illumina DNA Prep with Exome 2.5 Enrichment
A high-performance, fast, and reliable human whole-exome sequencing solution that includes a comprehensive, up-to-date exome enrichment panel.
NextSeq 500/550 v2.5 Reagent Kits
Ready-to-use reagent kits include the reagent cartridge, flow cell, and buffer. Multiple sequencing output and read length options available.
Variant analysis for target regions performed with BWA Genome Alignment Software and GATK Variant Caller.
Rapid alignment and variant detection tool using the Isaac Aligner.
Comprehensively target disease-associated regions of the exome with high analytical sensitivity and specificity.
NextSeq 500/550 v2.5 Reagent Kit
Ready-to-use reagent kits include the reagent cartridge, flow cell, and buffer. Multiple sequencing output and read length options available.
Variant analysis for target regions performed with BWA Genome Alignment Software and GATK Variant Caller.
Rapid alignment and variant detection tool using the Isaac Aligner.
Our variant annotation and analysis software tools can help researchers extract and report biological insights from large volumes of genomic data.
The NextSeq 550Dx Instrument is intended for targeted sequencing of DNA libraries from human genomic DNA extracted from peripheral whole blood or formalin-fixed, paraffin-embedded (FFPE) tissue when used with in vitro (IVD) diagnostic assays. The NextSeq 550Dx Instrument is not intended for whole genome or de novo sequencing. The NextSeq 550Dx Instrument is to be used with specific registered, certified, or approved in vitro diagnostic reagents and analytical software.
The NextSeq 550Dx instrument is intended for sequencing of DNA libraries when used with in vitro diagnostic assays. The NextSeq 550Dx instrument is to be used with specific registered, certified, or approved in vitro diagnostic reagents and analytical software.